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Summary
Objectives: The aim of this study was to investigate the topographic variation in matrix production and cell density in the adult human knee
joint. Additionally, we have examined the redifferentiation potential of chondrocytes expanded in vitro from the different locations.
Method: Full thickness cartilage-bone biopsies were harvested from seven separate anatomical locations of healthy knee joints from
deceased adult human donors. Chondrocytes were isolated, expanded in vitro and redifferentiated in a pellet mass culture. Biochemical anal-
ysis of total collagen, proteoglycans and cellular content as well as histology and immunohistochemistry were performed on biopsies and
pellets.
Results: In the biochemical analysis of the biopsies, we found lower proteoglycan to collagen (GAG/HP) ratio in the non-weight bearing (NWB)
areas compared to the weight bearing (WB) areas. The chondrocytes harvested from different locations in femur showed a signiﬁcantly better
attachment and proliferation ability as well as good post-expansion chondrogenic capacity in pellet mass culture compared with the cells
harvested from tibia.
Conclusion: These results demonstrate that there are differences in extra cellular content within the adult human knee in respect to GAG/HP
ratio. Additionally, the data show that clear differences between chondrocytes harvested from femur and tibia from healthy human knee joints
exist and that the differences are not completely abolished during the process of de- and redifferentiation. These ﬁndings emphasize the
importance of the understanding of topographic variation in articular cartilage biology when approaching new cartilage repair strategies.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Articular cartilage is a specialized tissue functioning as
a load-bearing surface in the synovial joints and has unique
biomechanical properties in order to resist stress in com-
pression, tension and shear during normal locomotion.
The ability of articular cartilage to perform its physiological
functions arises from the specialized structure, composition
and integrity of the extra cellular matrix (ECM) components.
The ECM in articular cartilage is produced by the chondro-
cytes and primarily consists of water, proteoglycans, and
collagen. The relationship between biomechanical charac-
teristics of articular cartilage with the constitution of the
tissue has been subjected to various studies1e3. Articular
cartilage composition and structure are locally conditioned
by different mechanical environment and show a topograph-
ical variation in the joint2,4,5. Areas in the joint that are*Address correspondence and reprint requests to: Dr Hanna
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1356subjected to a higher level of compression stress show
higher content of proteoglycans, which makes these areas
stiffer than areas subjected to low levels of stress6e8. Addi-
tionally, the elastic properties of articular cartilage show
a site-related correlation with the proteoglycan to collagen
(GAG/HP) ratio in the canine knee2. A topographic variation
in biomechanical properties of articular cartilage has further-
more been demonstrated to signiﬁcantly differ between
sites of high and low incidence of lesions9.
Due to the limited self-repair in cartilage, lesions to the
articular surface represent a major challenge for orthopedic
surgeons and the clinical need for cartilage reconstruction is
paramount. Numerous strategies, such as cell based thera-
pies and tissue engineering approaches, have therefore
emerged for cartilage reconstruction. Most of these tech-
niques require an initial phase of in vitro expansion of
autologous chondrocytes, which is either followed by a di-
rect injection of the cells at the site of lesion10, or used to
engineer implantable grafts11e13. During the in vitro expan-
sion the chondrocytes dedifferentiate and lose their round
shape; produce less cartilage speciﬁc matrix proteins,
such as collagen type II; and become ﬁbroblast like and pro-
duce increasing amounts of collagen type I14,15. To obtain
1357Osteoarthritis and Cartilage Vol. 16, No. 11adequate tissue once transplanted back into the defect, the
in vitro expanded cells have to redifferentiate and regener-
ate a tissue with sufﬁcient mechanical properties, i.e., carti-
lage with hyaline speciﬁc proteins.
However, there is a lack in knowledge of the pattern of
the ECM at different anatomical positions in the human
knee joint. Increased knowledge would provide valuable in-
sight in normal cartilage physiology and help to guide new
emerging cartilage repair approaches. A better understand-
ing of site speciﬁc ECM composition would also be of impor-
tance when designing scaffolds for cartilage tissue
engineering. Additionally, more site speciﬁc information of
the post-expansion chondrogenic capacity used in cell
based therapies and tissue engineering may help in the de-
sign of therapeutic strategies for the treatment of articular
cartilage defects. Therefore, the speciﬁc objects of this
study were to examine if cartilage, in respect to total colla-
gen, proteoglycans and cellular content, has a topographic
variation in the adult human knee joint and if chondrocytes
isolated from these locations possess similar ability to redif-
ferentiate after in vitro expansion.
Materials and methodsEXPERIMENTAL DESIGNA ﬂowchart illustrating the experimental set-up of analysis of the biopsies,
the in vitro expansion and the analysis of the chondrogenic capacity, is
shown in Fig. 1.BIOPSY HARVESTINGWith approval from the Ethics Commission in Warsaw cartilage biopsies
were harvested from three deceased donors, age 26e43 years (with a mean
age of 37 years). Four cylindrical full thickness cartilageebone biopsies were
harvested from seven different anatomical positions in the human joint. Biop-
sies were harvested from the surface of the patellar groove of femur (FPG),
from weight bearing (WB) and non-weight bearing (NWB) areas of the medial
and lateral condyles of femur (FMW, FLW, FMNW, FLNW), and fromWB area
of the medial and lateral condyles of tibia (TMW, TLW) from each donor (see
Fig. 2). The biopsies were harvested with a 5-mm diameter punch perpendic-
ular to the surface of the articular cartilage of the left knee from human donors
that hadmacroscopically intact cartilage and no known cartilage defect history.
The International Cartilage Repair Society (ICRS) score was used to standard-
ize the biopsy harvesting. The biopsies were put into physiological saline with
antibiotics for transportation. Three of the biopsies from the same anatomical
position were allocated for biochemical analysis and for cell culture and the
fourth biopsy was ﬁxated for histology/immunohistochemistry (see Fig. 1).
The wet weight of the biopsy was measured and about 1/6th of the biopsy
was taken for biochemical analysis and the rest to cell culture.INCLUSION CRITERIAThe Mankin score was performed as described previously16,17. The aver-
age of the Mankin score was calculated out of all the seven differentCartilage biopsy
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Fig. 1. Experimental set-up. For a detailed description, see Material
and methods.anatomical positions of the human knee joint and donors with an average
of the Mankin score below 217, were included in the study.CELL CULTUREChondrocytes were isolated by mechanical mincing followed by over night
collagenase digestion (type II clostridial collagenase, 0.8 mg/ml, Worthington
Biochemicals, Lakewood, New Jersey) at 37C and 7% CO2/93% air
10.
Isolated chondrocytes were cultured in Dulbecco’s modiﬁed eagle’s medium
(DMEM)/F12 (Invitrogen, Paisley, UK) supplemented with 0.025-mg/ml L-as-
corbic acid (Apotekets produktionsenhet Umea˚, Sweden), 1 PenicillineS-
treptomycin (PAA Laboratories), 2-mM L-Glutamine (Gibco) and with 10%
human serum. Generally, the ﬁrst medium change was made at day 6, at
day 7 a photo was taken and thereafter the media was changed twice
a week. Subculture was made with trypsin-ethylene diamine tetraacetic
acid (EDTA) solution [0.125% trypsin (Gibco) diluted in 0.1-M phosphate
buffered saline with 0.2-g/l EDTA] when the cells had reached 80% conﬂu-
ence. At the subculture number of cells was counted and the time to reach
80% conﬂuences noted.PELLET CULTUREThe matrix production capacity of the expanded chondrocytes was ana-
lyzed in a 3D pellet culture system as described earlier18,19. Brieﬂy,
2.0 105 cells from passage 1, were placed into polypropylene conical tubes
with 0.5 ml of deﬁned medium, consisting of DMEM-High glucose (PAA Lab-
oratories, Linz, Austria) supplemented with insulin-transferrin-selenium
(ITSþ) (Life Technologies, Sweden), 5.0-mg/ml linoleic acid (Sigma-Aldrich,
Stockholm, Sweden), 1.0-mg/ml human serum albumin [HSA (Equitech-
Bio, TX, USA)], 10-ng/ml transforming growth factor beta 1 (TGF-b1) (R&D
Systems, UK), 107-M dexamethasone (Sigma), 14-mg/ml ascorbic acid
(Sigma) and 1 PenicillineStreptomycin (PAA Laboratories). The cells
were centrifuged at 500 g for 5 min and maintained in 37C in 7% CO2/
93% air. Six to eight pellets were cultured from each biopsy for 14 days
and the medium was changed twice a week. Four to six pellets were further
analyzed with biochemical methods and two pellets were ﬁxed for supple-
mentary histological and immunohistochemical analyses.HISTOLOGY OF BIOPSIES AND PELLETSBiopsies and pellets were ﬁxed in Histoﬁx (Histolab products AB,
Gothenburg, Sweden), dehydrated and embedded in parafﬁn. Five microm-
eter sections were cut and placed onto microscope slides (Superfrost Plus,
Menzel-Gla¨ser, Germany), deparafﬁnized and stained with Alcian blue/van
Gieson, Safranin-O or immunoassayed with anti-type I collagen and anti-
type II collagen as described below. The stained sections were analyzed
by a Nikon Optiphot2-pol microscope (Nikon Instruments Inc, Melville, NY,
USA) and digital pictures were taken with automatic camera tamer (ACT-1)
software (Nikon, Japan).
The chondrogenic capacity of the pellets was further analyzed with the Bern
Score system20. Brieﬂy, the sections were graded according to intensity of the
matrix staining, cell density/extent of matrix produced and cell morphology.IMMUNOHISTOCHEMISTRY OF BIOPSIES AND PELLETSImmunohistochemistry was performed, with a modiﬁed method, as de-
scribed previously19. Brieﬂy, sections from cartilage biopsies and pellets
were deparafﬁnized, dehydrated, and digested with hyaluronidase, 8000 U/
ml (Sigma-Aldrich) and further with chondroitinase AC, 0.05 U/ml (Sigma-
Aldrich). Endogenous peroxidase activity was quenched with 3% H2O2
and the sections were blocked with 3% bovine serum albumin (BSA)
(Sigma-Aldrich). Primary antibodies raised against Collagen types I and II
(ICN Biomedicals, Aurora, OH, USA) were incubated 1 h at room tempera-
ture or over night at 4C. A horse radish peroxidase (HRP) conjugated sec-
ondary antibody (Jackson Laboratory, Maine, ME, USA) was added to the
sections for 1 h and visualized using the TSA-Direct Cy3 kit (Perkin Elmer,
Boston, MA, USA) according to the manufacturer’s instructions. Nuclei
were stained with 40, 6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich).
The sections were analyzed with Nikon ﬂuorescence microscope and digital
pictures were taken with ACT-1 software.BIOCHEMICAL ANALYSIS OF PELLETS AND BIOPSIESThe biochemical content was studied in respect to the seven distinct
anatomical positions as well as the ratio between NWB to WB areas, femur
to tibia, and medial to lateral side. Biochemical analysis of the biopsies and
pellets was performed as described earlier21. Brieﬂy, the biopsies and pellets
were digested in papain (Sigma) solution [0.3-mg papain/ml sodium phos-




































Fig. 2. Schematic picture of biopsy harvesting adapted from the ICRS score. To standardize the biopsy harvesting the ICRS score was used
with kind permission from ICRS. Indicating one biopsy. FMNW and FLNW: NWB areas of the medial and lateral condyles of femur, respec-
tively; FMW and FLW: WB areas of the medial and lateral condyles of femur, respectively; FPG: femur patellar groove; TMW and TLW: WB
areas of the medial and lateral condyles of tibia, respectively.
1358 H. Stenhamre et al.: Topographic variation in chondrogenicityor for 90 min at 60C, respectively. The digested samples were then further
analyzed for DNA, proteoglycan (GAG) and hydroxyproline (HP) content.
The amount of DNA was measured with Hoescht 33258 (Sigma), according
to the manufacturer’s instruction and the GAG and HP content as previously
described21. All biochemical analyses were made in duplicates from dupli-
cate or triplicate samples.STATISTICAL ANALYSISStatistical analysis was performed by the non-parametric ManneWhitney
U test. P-values less than 0.05 were considered signiﬁcant.ResultsHISTOLOGY AND IMMUNOHISTOCHEMISTRY












syThe inclusion criteria in this study were macroscopically
intact cartilage, no known cartilage defect history, and an
average Mankin score less than 2. The Mankin sore was
performed as described previously17. The average Mankin
score in the three patients was 1.6 0.3. In general, the
WB areas on the medial side of both femur and tibia had
a slightly higher Mankin score than the corresponding
lateral side.
The histological staining for proteoglycans, Alcian blue/
van Gieson and Safranin-O, demonstrated high GAG
content in all layers of the biopsies except in the surface
zone (see Fig. 5). The biopsies harvested from tibia
contained less amounts of proteoglycan than biopsies
from femur as indicated by weaker Alcian blue/van Gieson
and Safranin-O staining. The subtypes of collagen, types I
and II, were qualitatively demonstrated by immunohisto-
chemical staining with antibodies. In general, collagen
type I was only detected in the surface of the biopsies
whereas collagen type II was detected throughout all the
layers. No topographic variation in the collagen type I or
collagen type II expression was observed (see Fig. 5).500
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Fig. 3. A graph presenting number of cells per wet weight biopsy.
The number of cells per wet weight biopsy in the different localiza-
tions at the time of isolation. *Indicates a signiﬁcant difference with
P< 0.05; n¼ 3.Cellular content in the biopsies
To further characterize the biopsies, both DNA measure-
ments and traditional cell counting with a hematocytometer
were used to analyze the number of cells per mg wet weight
biopsy. The two different methods showed good correlation(data not shown) and the average cell number per mg
biopsywas 1483 371 (see Fig. 3). The highest cellular con-
tent was detected in the condyles of femur. Moreover, the fe-
mur/tibia ratio showed a 55% higher cells/mg biopsy in femur
than in tibia, i.e., 1643 257and 1084 143 cells/mg, re-
spectively. A difference in cellular content was also observed
between the NWB and WB areas, i.e., 12% higher cells/mg
biopsy content in the NWB biopsies (Fig. 4).
ECM content in the biopsies
The proteoglycan to collagen (GAG/HP) ratio showed
a site-dependent variation in all patients. In the NWB areas,
the average of GAG/HP ratio was 38% lower than in the WB
areas (see Table I). To examine whether the trend seen in
the GAG/HP ratio was due to the proteoglycan or collagen
content, the topographic variation of the matrix components
was studied in respect to the wet weight of the biopsy. In
NWB biopsies, the GAG content varied from 23 to 47 mg
GAG/mg biopsy while in WB biopsies the corresponding
values were 17e74 mg GAG/mg biopsy. The total collagen
content, as seen by amount of HP, had a larger variance
between the different locations of the knee joint in the three
patients. The non-weight bearing areas ranged from 1.7 to
16.9 mg HP/mg biopsy and WB from 0.4 to 9.8. In average,
the amount of GAG was 8% lower and the amount of HP
was 78% higher in the NWB areas when compared to the
WB areas.


































Fig. 4. Normalized levels of biochemical analyses of biopsies.
Normalized biochemical analyses of the ECM and cellular content
of biopsies harvested from different topographic locations in the
human knee joint; GAGs-to-HP, GAG-to-DNA and HP-to-DNA
ratio; n¼ 3.
1359Osteoarthritis and Cartilage Vol. 16, No. 11The histological analysis of the biopsies indicated
a difference in the matrix composition between tibia and
femur. This observation was conﬁrmed with the biochemical
analysis and in average all patients had about 44% higher
mg GAG/mg biopsy and 85% mg HP/mg biopsy in femur
compared to tibia. The GAG content in femur varied from
18 to 73 mg GAG/mg biopsy and in tibia from 16 to 42.
The corresponding values for the HP content were
0.7e16.9 mg HP/mg biopsy for femur and 0.4e7.4 mg HP/
mg biopsy for tibia. The large variance in ECM content
was seen when comparing all three patients. Within each
patient the variance was smaller, as seen in Table II.IN VITRO EXPANSIONA clear difference in the expansion behavior of chondro-
cytes harvested from femur and tibia was observed. TheFig. 5. Histology and immunohistochemistry of biopsies. Representative
the human knee joint stained with Alcian Blue/van Gieson (nuclei staine
stained black, sulfated proteoglycans stained red), and antibody raised ag
matrix stainecells isolated from femur showed good attachment and pro-
liferation rate while most cells isolated from tibia biopsies
showed low attachment and proliferation. In average, the
cell doublings per day were 0.24 0.02 for chondrocytes
harvested from femur, whereas cells isolated from tibia
had a cell doubling per day at 0.09 0.14. A slight non-
signiﬁcant difference was noted between the NWB and
corresponding WB position in femur, i.e., 0.26 0.03 and
0.22 0.00, respectively.HISTOLOGY AND IMMUNOHISTOCHEMISTRY OF THE PELLETSTo study the redifferentiation capacity of the in vitro ex-
panded chondrocytes, the cells were placed into pellet
mass culture in passage 1, i.e., after 3.8 1 population-
doublings. The cells were cultured as 3D-pellets in rediffer-
entiation medium for 2 weeks and then harvested and
analyzed. In general the pellets originating from biopsies
harvested in femur were signiﬁcantly larger and contained
more matrix proteins than those from tibia. All pellets from
femur had high proteoglycan and collagen type II expres-
sion and a modest collagen type I expression were detected
in a few pellets. In contrast, the pellets produced with chon-
drocytes expanded from tibia contained low amounts of
proteoglycans indicated by weak Alcian blue/van Gieson
and Safranin-O staining. The tibia pellets contained colla-
gen type I and modest amounts of collagen type II (see
Fig. 7). The Bern score20 of the pellets was signiﬁcantly
higher in the pellets originating from femur compared to
the ones from tibia (7.1 0.60 and 3.5 0.04, respectively).
No difference in the Bern score was detected between the
different anatomical positions in femur.BIOCHEMICAL ANALYSIS OF THE PELLETSThe proteoglycan content of the pellets was considerably
higher in the pellets originating from chondrocytes har-
vested in femur compared to tibia, i.e., 4.9 3 times higher
(see Fig. 6). The GAG content in the pellets originating from
femur varied from 16 to 76 mg GAG/pellet and in tibia fromcartilage biopsies harvested from different topographic locations in
d black, sulfated proteoglycans stained blue), Saffranin-O (nuclei
ainst collagen type II (nuclei stained blue using DAPI and collagen
d red).
Table I
Comparison of the ECM content in the joint. The ratio of femur vs
tibia and non-weight bearing areas (NWB) vs weight bearing areas
(WB) in respect to the ECM and cellular content in the adult human
knee joint n¼ 3
GAG GAG HP
HP std DNA std DNA std
Femur/tibia 1.00 0.09 0.87 0.16 0.80 0.19
NWB/WB 0.62 0.04 0.80 0.04 1.56 0.71






















ug DNA/pellet ug GAG/ug DNA
ug HP/ug DNA ug GAG/ug HP
Fig. 6. Normalized levels of biochemical analyses of pellets. Nor-
malized biochemical analyses of the ECM and cellular content of
the pellets originating from different topographic locations in the
human knee joint.
1360 H. Stenhamre et al.: Topographic variation in chondrogenicity3 to 17 mg GAG/pellet. To further study the importance of
the choice of sampling site, the redifferentiation capacity
of chondrocytes harvested from different localizations in
femur was investigated. The production of proteoglycans
per cell was higher in the pellets originating from the
NWB areas when compared to the corresponding WB
area of femur. The GAG production per cell varied from
91 to 115 mg GAG/mg DNA in the NWB area and
26e94 mg GAG/mg DNA in corresponding WB site. The
NWB areas had further a higher mg GAG/mHP, i.e., 19%,
when compared with the corresponding WB site. Notewor-
thy, the values of the ECM components in respect to DNA
were about 10 times lower in the pellets than in the cartilage
biopsies and that the cells harvested from tibia of one of the
donors did not proliferate at all.Discussion
Articular cartilage from distinct anatomical locations in the
joint of young and middle-age humans (26e43 years of
age) were subjected to a thorough analysis of the ECM
and cellular content. Additionally, the redifferentiation
capacity of in vitro expanded chondrocytes harvested
from the different localizations was examined. In this study
we demonstrate that there are differences in ECM content
within the adult human knee in respect to GAG/HP ratio.
Additionally, the data show that clear differences between
chondrocytes harvested from femur and tibia from a healthy
human knee joint exists and that the differences are not
completely abolished during the process of de- and
redifferentiation.
Data regarding the biochemical composition of articular
cartilage is useful for the understanding of tissue function
in health and disease. The biochemical properties of articu-
lar cartilage vary considerably throughout the knee joint.
The topographic variations are related to local differences
in the type and degree of mechanical loading the area is
subjected to2,5. Furthermore it has been reported that the
equilibrium response of articular cartilage is governed byTable II
ECM and cellular content in distinct localization of the human knee.
Summary of results of ECM in human articular cartilage from seven
different locations in the adult human knee joint from a representa-
tive patient. *indicates p < 0.05 in respect to ** n¼ 3
mg GAG mg GAG mg HP
mg HP std mg Biopsy std mg Biopsy std
FMNW 4.6 0.9** 27.0 8.0* 6.2 2.8
FLNW 4.4 0.2* 40.7 21.0* 10.8 4.9
FMW 8.8 2.2 73.5 9.9* 7.4 1.4
FLW 8.9 1.1* 47.3 9.2** 5.4 1.5
FPG 11.6 4.5* 47.4 10.9 4.4 1.5
TMW 9.1 3.7* 42.3 12.1* 4.9 1.5
TLW 6.3 1.5 26.2 1.7* 5.0 1.2the elastic properties of the tissue. Jurvelin et al. have dem-
onstrated that the Poisson’s ratio, i.e., elastic property, of
articular cartilage has a negative correlation to the collagen
to proteoglycan content in the canine knee joint. Moreover
this correlation showed a site-related variation2. This is in
agreement with our data demonstrating that the GAG/HP
ratio is lower in the NWB areas than in the WB areas of
the human knee joint. However, in the WB areas our data
did not correlate with the GAG/HP ratio found at the same
anatomical locations in the canine joint2. This could be
due to species variation and that the loading pattern differs
between the species. Nevertheless, various studies have
demonstrated that areas subjected to high levels of com-
pression stress show a higher content of proteoglycans,
which are in accordance to our data2,3,6,8. Furthermore
our results demonstrate that the collagen content is higher
in the NWB areas. These data are similar with previous
published data showing a higher collagen content in areas
subjected to intermittent peak loads compared to areas
with constantly loading in standing and moving6. Our results
show that there is no signiﬁcant difference in GAG or HP
content between the seven distinct anatomical positions,
when comparing all patients, which conﬁrms Garcia-Seco
et al.’s results22. The values for total collagen and proteo-
glycan content varied greatly for a given measurement
site. The large variability observed in the biochemical anal-
ysis of the different individuals could be due to factors of
a variety of nature, such as lifestyle, previous drug treat-
ment and sport activities. The large variation in the
biochemical content has previously been observed in
human articular cartilage16.
In this study the cell yield from a cartilage biopsy
harvested from femur was larger than in biopsies from tibia
in the same patient. This suggests that the cell reduction
process in articular cartilage may be faster and more dom-
inant in tibia than femur. Additionally, our results show that
the number of cells isolated from a cartilage biopsy
harvested from the medial side of tibia is smaller than
from the lateral side. It has previously been demonstrated
that the medial compartment has a higher prevalence of
osteoarthritis (OA) than the lateral compartment23. Taken
together this indicates that an increase of acellularity of
human articular cartilage might relate to its diminishing
capacity for self-repair, since fewer cells become responsi-
ble for increasingly large areas of matrix.
Fig. 7. Histology and immunohistochemistry of pellets. Representative pellets originating from the seven distinct localizations in the human
knee joint stained with Alcian Blue/van Gieson (nuclei stained black, sulfated proteoglycans stained blue), Saffranin-O (nuclei stained black,
sulfated proteoglycans stained red) and antibody raised against collagen type II (nuclei stained blue using DAPI and collagen matrix stained
red).
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ences in the ability to attach and proliferate were seen
between femur and tibia. The culture method used in this
study is optimized for chondrocytes used in autologous
chondrocyte transplantation (ACT) in which cells are
harvested from a NWB area in femur10. To obtain a better
attachment and proliferation of the chondrocytes harvested
from tibia the culture conditions could be optimize for these
cells by for example the addition of growth factors in the
culture media or by coating of culture ﬂasks. However, by
having different culture methods during the expansion of
the chondrocytes harvested from different locations in the
human knee the post-expansion chondrogenicity could be
due to either the diverse culture conditions used during
the expansion or by the fact that the cells originate from
different localizations in the joint. The ability of the chondro-
cytes to attach and proliferate could also be due to the age
of the patients. It has been demonstrated that there is an
age-related reduction of the proliferation rate of articular
chondrocytes, which corresponds with our results24,25.
Our results demonstrate that the chondrocytes harvested
from tibia from the youngest patient (26 years) had a better
ability to attach and proliferate than the other patients (40
and 43 years of age).
The redifferentiation capacity of the in vitro expanded
chondrocytes did not correlate with the age as previously
described by Barbero et al.25. A signiﬁcant difference was
seen in the post-expansion chondrogenic capacity between
cells originating from femur and tibia. Even when the attach-
ment and proliferation rate were similar, the post-expansion
chondrogenic capacity between chondrocytes harvested
from femur was signiﬁcantly higher compared to cells from
tibia. The pellets originating from NWB areas in femur had
more ECM production per cell than corresponding WB
site. Taken together, our results indicate that the dedifferen-
tiation and redifferentiation did not completely abolish the
differences of the chondrocytes originating from either
femur or tibia. Cell based methods of surgical repair thera-
pies of articular cartilage injuries, such as ACT, have made
it possible for successful generation of a hyaline-like repair
tissue with correct biomechanical properties of articular
cartilage10. The ﬁndings of this study verify that harvestinga biopsy from a NWB area of the femur condyle will give
the best opportunity for cartilage regeneration using in vitro
expanded chondrocytes when performing an ACT. More-
over, an inverse correlation between the biopsies and
pellets in femur with respect to GAG/HP and GAG/DNA
was observed in this study. The amount of proteoglycan
or collagen per cell was, however, about 10 times lower in
pellets than in the biopsies they originated from. The differ-
ence of the chondrocytes ability of redifferentiate after
in vitro expansion observed could possibly originate from
their in vivo situation. It is well documented that articlular
cartilage is an inhomogeneous tissue where the organiza-
tion of collagen and proteoglycan concentration regulates
the biomechanical properties of the tissue4. Chondrocyte
phenotypic expression and biosynthetic activities may be
altered by loading of the cartilage ECM26. The chondrocytes
in the WB areas of femur produces more proteoglycans per
cell indicating that these cells in average are more differen-
tiated than cells found in corresponding NWB area. It has
furthermore been suggested that articular chondrocytes
need to dedifferentiate to a certain extent to achieve good
redifferentiation in the pellet mass system27. During the in
vitro expansion the cells from different localizations did
approximately the same number of population-doublings.
The different ability of the post-expansion chondrogenic
capacity observed in this study might be due to what state
of dedifferentiation the in vitro expanded chondrocytes
had when put into pellet mass culture. Taken together these
ﬁndings might designate that there is a distinction in the
differentiation grade of the chondrocytes from diverse ana-
tomical positions in the human joint. Moreover, our results
indicate that these differences are not completely elimi-
nated during the process of de- and redifferentiation.
Even though the number of knees and cartilage biopsies
studied were small, our results demonstrated that there are
differences in ECM content between the WB and NWB
localizations within the adult human joint in respect to GAG/
HP ratio. Knowledge of the biochemical properties of human
articular cartilage is a useful basis for further investigation into
the effects of different treatments of articular cartilage defects
as well as understanding the progression of OA. Further,
these ﬁndings highlight that the choice of sampling sites
1362 H. Stenhamre et al.: Topographic variation in chondrogenicitymay inﬂuence the outcome of cartilage repair and biochemi-
cal studies of articular cartilage and therefore must be inter-
preted with care. Additionally, we demonstrate that a clear
difference in post-expansion chondrogenic capacity between
chondrocytes harvested from femur and tibia from a healthy
human joint exists and that these differences are not com-
pletely abolished during the process of de- and redifferentia-
tion. These ﬁndings emphasize the importance of
understanding the topographic variation of the articular carti-
lage biology when approaching new articular cartilage cell
based and tissue engineering repair strategies.Conﬂict of interest
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